Welcome to our dedicated page for Auxly Cannabis news (Ticker: CBWTF), a resource for investors and traders seeking the latest updates and insights on Auxly Cannabis stock.
Auxly Cannabis Group Inc. (OTCQB: CBWTF; TSX: XLY) generates frequent news as a Canadian consumer packaged goods company focused on cannabis products. Company updates center on its branded dried flower, pre-roll and vape offerings, its financial performance, and developments in its capital structure.
News items often cover quarterly and interim financial results, where Auxly reports on net revenues, gross margin on finished cannabis inventory sold, adjusted EBITDA and net income. These releases also highlight commercial metrics such as national market share, category leadership in all-in-one vapes and non-infused pre-rolls, and the performance of key brands like Back Forty, Liquid Imagination and Fire Breath.
Auxly’s news flow also includes announcements about strategic and financial transactions. Examples include amendments and extensions to its credit facility with a syndicate of lenders led by the Bank of Montreal, the settlement of amounts owing to Imperial Brands plc through equity and pre-funded warrants, and the repayment of specific inventory loans. The company presents these developments as steps that reduce debt, lower interest expense and strengthen its balance sheet.
Operational and corporate updates can feature product and brand innovations, such as the launch of Back Forty Backpackers pre-rolls and the introduction of the South Point brand, as well as expansion into new provincial markets like Quebec. Governance and shareholder-related items, including annual meeting results and board elections, are also disclosed through news releases.
Investors and observers following CBWTF news can use this page to track Auxly’s earnings reports, capital structure changes, brand and product announcements, and other corporate communications that the company distributes through wire services.
Auxly Cannabis Group Inc. (OTCQX: CBWTF) announced it will report its third quarter 2021 earnings results on November 15, 2021, before the market opens. The company will host a conference call at 10:00 a.m. EST to discuss the results. Auxly focuses on innovative cannabis products for the wellness and adult-use markets, backed by a robust supply chain and R&D capabilities. The earnings report and call are expected to provide insights into the company's financial performance and strategic direction, crucial for shareholders and investors.
Auxly Cannabis Group has solidified its position as the #6 licensed producer in Canada for cannabis sales as of Q3 2021, achieving a 5.7% market share, up from 4.9% in Q2. The company leads in Cannabis 2.0 product sales with a 15.6% market share, notably holding 24.7% of the vapour market. Auxly plans to reach 7-9% market share by year-end and aims for positive adjusted EBITDA. The growth is attributed to innovative product launches and focused consumer connections, ensuring continuous expansion in the competitive landscape.
Auxly Cannabis Group (OTCQX: CBWTF) reported Q2 2021 net revenues of $20.9 million, more than double from Q2 2020. This growth is attributed to a 204% increase in cannabis sales, largely from Cannabis 2.0 products, improving market share to 4.9%. Adjusted EBITDA improved to negative $3.3 million, a 68% enhancement year-over-year. The net income attributable to shareholders reached $8.7 million. The company aims for positive adjusted EBITDA by year-end and continues to focus on expanding product offerings in the cannabis market.
Auxly Cannabis Group (OTCQX: CBWTF) will report its Q2 2021 earnings on August 16, 2021, before the market opens. The company provides innovative cannabis products for wellness and recreational markets, supported by a strong supply chain and R&D capabilities. A conference call will be held on the same day at 10:00 a.m. EST to discuss the financial results. Investors can access the replay on the company's website within 24 hours of the call.
Auxly Cannabis Group announces its exciting summer product lineup featuring popular brands like Kolab Project, Back Forty, Foray, and Dosecann. The company, which holds a 5.2% market share, recently made a strong entry into the dried flower market with Back Forty Pine Kush, capturing approximately 2% of the national flower market in June. The new offerings include unique strains, pre-rolls, and edibles aimed at enhancing consumer experience. Auxly continues to prioritize innovation and consumer insights to drive sales in a market worth over $2 billion annually.
Auxly Cannabis Group (OTCQX: CBWTF) announced amendments to a $123 million debenture and investor rights agreement with Imperial Brands. Key changes include a 24-month extension of the maturity date to September 25, 2024 and an annual right for Imperial to convert unpaid interest into common shares. The Company also completed the sale of its interest in Curative Cannabis for $6 million, strengthening its financial position without diluting shareholders. The amendments received minority shareholder approval on June 28, 2021.
Auxly Cannabis Group (OTCQX: CBWTF) announced the results of its annual general and special meeting held on June 28, 2021, where 132,758,409 common shares (17.62% of total shares) were voted. All resolutions, including the election of directors and the approval of Ernst & Young as auditors, received requisite majority support. Notably, the Imperial Amendment Resolution garnered 99.26% approval, excluding votes from Imperial Brands. The company continues to focus on delivering high-quality cannabis products in the wellness and adult-use markets.
Auxly Cannabis Group Inc. (OTCQX: CBWTF) announced its Annual General and Special Meeting of Shareholders on June 28, 2021, at 2:00 p.m. EST. To limit COVID-19 risks, physical attendance is discouraged. Only registered shareholders and appointed proxyholders can attend, requiring 48 hours' advance notice. The meeting will feature an audio teleconference, but voting will not be allowed via this method. Shareholders are encouraged to vote in advance. Questions can be submitted beforehand for potential responses during the call.
Auxly Cannabis Group Inc. (OTCQX: CBWTF) reported Q1 2021 financial results with net revenues of $10 million, a 1% increase from Q1 2020. The company maintained a strong market presence in Cannabis 2.0 products, holding 12.6% market share. SG&A expenses decreased by 5%, contributing to a reduced net loss of $10.5 million, down from $13.2 million in the previous year. Despite facing challenges from COVID-19 and inventory management changes, retail sales showed resilience. The company raised $8 million through a private placement to strengthen its balance sheet.
Auxly Cannabis Group Inc. (OTCQX: CBWTF) has announced a definitive agreement for Myconic Capital Corp. to acquire KGK Science Inc. for up to $16.5 million. The deal includes $12.5 million in purchase price, $1.5 million milestone payment for achieving $8 million in revenue, and $2.5 million in future service credits. This transaction is expected to close around June 7, 2021, pending regulatory approvals. Auxly aims to use the capital to optimize operations and enhance profitability, leveraging KGK’s expertise in the cannabis sector.
FAQ
What is the current stock price of Auxly Cannabis (CBWTF)?
What is the market cap of Auxly Cannabis (CBWTF)?
